Amgen Balance Sheet Health
Financial Health criteria checks 2/6
Amgen has a total shareholder equity of $7.7B and total debt of $60.5B, which brings its debt-to-equity ratio to 789.8%. Its total assets and total liabilities are $90.5B and $82.9B respectively. Amgen's EBIT is $9.7B making its interest coverage ratio 3.9. It has cash and short-term investments of $34.7B.
Key information
789.8%
Debt to equity ratio
US$60.47b
Debt
Interest coverage ratio | 3.9x |
Cash | US$34.74b |
Equity | US$7.66b |
Total liabilities | US$82.88b |
Total assets | US$90.53b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 000907582's short term assets ($48.5B) exceed its short term liabilities ($17.0B).
Long Term Liabilities: 000907582's short term assets ($48.5B) do not cover its long term liabilities ($65.9B).
Debt to Equity History and Analysis
Debt Level: 000907582's net debt to equity ratio (336%) is considered high.
Reducing Debt: 000907582's debt to equity ratio has increased from 239.9% to 789.8% over the past 5 years.
Debt Coverage: 000907582's debt is not well covered by operating cash flow (17.5%).
Interest Coverage: 000907582's interest payments on its debt are well covered by EBIT (3.9x coverage).